Caroline D. Dorsa's most recent trade in Biogen Inc was a trade of 3,160 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 3,160 | 31,002 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 3,780 | 15,194 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.62 per share. | 16 May 2025 | 1,070 | 11,414 (0%) | 0% | 83.6 | 89,473 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Purchase of securities on an exchange or from another person at price $ 122.72 per share. | 02 May 2025 | 1,235 | 27,842 (0%) | 0% | 122.7 | 151,559 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 121.33 per share. | 01 May 2025 | 1,607 | 11,121 (0%) | 0% | 121.3 | 194,977 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,785 | 26,607 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 2,622 | 12,431 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.01 per share. | 15 May 2024 | 612 | 9,809 (0%) | 0% | 115.0 | 70,386 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 103.06 per share. | 09 May 2024 | 1,698 | 9,514 (0%) | 0% | 103.1 | 175,000 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 1,580 | 24,822 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,532 | 10,421 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.65 per share. | 24 May 2023 | 492 | 8,889 (0%) | 0% | 212.7 | 104,624 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 98.15 per share. | 04 May 2023 | 1,783 | 7,816 (0%) | 0% | 98.1 | 175,000 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 23,242 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 12,701 (0%) | 0% | 0 | Common Stock | |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 110.05 per share. | 05 May 2022 | 1,590 | 6,031 (0%) | 0% | 110.1 | 174,980 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 21,872 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 3,382 | 3,382 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 2,094 | 2,094 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Sale of securities on an exchange or to another person at price $ 450.00 per share. | 10 Jun 2021 | 1,000 | 8,501 (0%) | 0% | 450 | 450,000 | Common Stock |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 881 | 9,501 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 397.09 per share. | 25 May 2021 | 385 | 8,620 (0%) | 0% | 397.1 | 152,880 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 100.57 per share. | 06 May 2021 | 1,591 | 4,441 (0%) | 0% | 100.6 | 160,000 | Common Stock |